Drug
Tyramine
Tyramine is a pharmaceutical drug with 3 clinical trials. Historical success rate of 66.7%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(33%)
Phase Distribution
Ph phase_3
1
33%
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 3Large-scale testing
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (66.7%)
Phase 31 (33.3%)
Trials by Status
terminated133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
terminatedphase_1
A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood Pressure
NCT03979820
completedphase_1
Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response
NCT03694119
completedphase_3
A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.
NCT00203125
Clinical Trials (3)
Showing 3 of 3 trials
NCT03979820Phase 1
A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood Pressure
NCT03694119Phase 1
Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response
NCT00203125Phase 3
A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3